Cordlife Group
Cordlife Group Limited founded in 2001, is a leading company dedicated to safeguarding the well-being of mother and child.
Cordlife renews cord blood and human tissue banking licences
Cordlife renews cord blood and human tissue banking licences
Conditions were set specifically for its cord blood banking permit.
Cordlife faces $5.45m in claims over 109 damaged cord blood units
It was ordered by the court to pay clients $50,000 per damaged unit.
Health ministry suspends Cordlife’s blood banking license
Cordlife is suspended from collecting, testing, processing, or storing new cord blood units.
Cordlife writes response to MoH on blood bank suspension
The MoH plans to suspend Cordlife's blood banking licence for a year.
Cordlife granted extension to appeal license suspension
The company stopped collection of cord blood units before suspension period
Cordlife to assess ‘going concern’ viability amidst potential suspension
The company said it cannot determine the financial impact for FY2025.
Cordlife faces one-year suspension for cord blood banking service
The suspension requires the company to ensure the safety and quality of its cord blood units.
Cordlife posts $4.6m net loss for H1 2025
Revenue amounted to $19.2m for the period.
IFA deems Cordlife's partial offer not fair and not reasonable
Medeze Treasury proposed to acquire 25.63 million shares in Cordlife at $0.25 each.
Cordife Group taps Chen Xiaoling as new group CEO
Chen was also appointed as Singapore CEO.
Cordlife appoints independent financial advisor for partial offer
The offer is for 10.68% shares in the company.
Cordlife faces new legal claims over stored cord blood issues
The company is currently seeking legal advice and will respond to the claims accordingly.
Cordlife posts $18.7m net loss in FY2024
The group’s revenue also plunged to $27.8m.
Cordlife CEO Yiu Pang Fai resigns
A search for a replacement is now being conducted.
Cordlife CFO updates on CAD probe
Cordlife will assess its CFO’s continuous appointment.
Cordlife renews licenses for one year
The group was instructed by the MOH to conduct operations in a controlled manner.
Cordlife Group directors waive fees for FY2024 amidst shareholder inquiries
The move comes after shareholder inquiries ahead of an extraordinary general meeting.
Read Here
Advertise
Sign Up
Commentary
Where does value creation really happen?
Managing the cost of diverging standards: Why Singapore matters
Singapore’s AI ambition has an intelligence problem
Singapore is deploying AI at speed – and security risks are catching up
Precious metal boom is a stress test for Singapore’s gold ambitions
Singapore’s global dispute fault lines
‘Tokenmaxxing’ – The wrong AI race to run in Singapore
To outsmart modern fraud, we must first know the enemy
Why Singapore SMEs cannot wait for quantum cyber risk to arrive before securing data